Editors Choice
Stereotactic laser amygdalohippocampotomy
The report of Willie, Jon T et al., demonstrates the technical feasibility and encouraging early results of stereotactic laser amygdalohippocampotomy (SLAH), a novel approach to eliminating seizures while minimizing collateral injury in patients with mesial temporal lobe epilepsy (MTLE). Efficacy appears to approach that of open resection, especially in patients with mesial temporal sclerosis (MTS). Such minimally invasive techniques may be more desirable to patients and result in increased use of epilepsy surgery among the large number of medically intractable epilepsy patients. A larger, longer term multicenter study of seizure and cognitive outcomes after SLAH is currently under way 1).
1) Willie JT, Laxpati NG, Drane DL, Gowda A, Appin C, Hao C, Brat DJ, Helmers SL, Saindane A, Nour SG, Gross RE. Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery. 2014 Jun;74(6):569-85. doi: 10.1227/NEU.0000000000000343. PubMed PMID: 24618797.